News|Slideshows|June 30, 2025

June Pharmaceutical Industry Movers & Shakers

A monthly roundup of business and people news in the pharmaceutical industry.

Newsletter

Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.

Subscribe

Related Content

EMA’s CHMP Recommends Eli Lilly’s Jaypirca for Approval

ByMike Hollan

June 26th 2026

The New Healthy Aging Imperative and What It Means for Pharma

ByKirsten Whipple

June 26th 2026

Jessica Dunne, US Medical, Autoimmune Diabetes Medical Director at Sanofi

Reading Between the Lines: Closing the T1D Misdiagnosis Gap

ByJessica Dunne

June 26th 2026

Pharmaceutical Executive Daily: FDA Clears Trodelvy for First-Line Metastatic Triple-Negative Breast Cancer

ByMike Hollan

June 25th 2026

Beyond the Strip: Las Vegas Has a New Kind of Venture in Mind

ByJoe Petroziello

June 25th 2026

June Pharmaceutical Industry Movers & Shakers

Related Content

EMA’s CHMP Recommends Eli Lilly’s Jaypirca for Approval

The New Healthy Aging Imperative and What It Means for Pharma

Reading Between the Lines: Closing the T1D Misdiagnosis Gap

Pharmaceutical Executive Daily: FDA Clears Trodelvy for First-Line Metastatic Triple-Negative Breast Cancer

Beyond the Strip: Las Vegas Has a New Kind of Venture in Mind

Trending on PharmExec

EMA’s CHMP Recommends Eli Lilly’s Jaypirca for Approval

Reading Between the Lines: Closing the T1D Misdiagnosis Gap

The New Healthy Aging Imperative and What It Means for Pharma

FDA Clears Trodelvy for First-Line Metastatic Triple-Negative Breast Cancer

Eli Lilly and Abbisko Announce Drug Development Collaboration